The regulatory gap is narrowing between nutritional supplements, food, personal care, and OTC Pharmaceuticals. Increasingly the FDA and other regulatory bodies are forcing compliance issues formerly reserved for big pharma into the corporation making up this segment of the consumer goods market.
The top global players in this segment include
GlaxoSmithKline, Merck Consumer Care, Novartis OTC, Pfizer Consumer Health, Sanofi-Aventis Consumer Health, Bayer Consumer Health, Johnson & Johnson, Procter & Gamble, Unilever, Reckitt Benckiser and others. While many top companies are owned by big pharma companies, the consumer health category must operate in the hyper competitive fast moving consumer goods business and be careful not to be mired down by the typically bureaucratic big pharma culture of the parent company in order to service the demanding retailers and consumers alike.
